Ebru Hacıosmanoğlu

436 total citations
27 papers, 326 citations indexed

About

Ebru Hacıosmanoğlu is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Ebru Hacıosmanoğlu has authored 27 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Toxicology. Recurrent topics in Ebru Hacıosmanoğlu's work include Synthesis and biological activity (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Ebru Hacıosmanoğlu is often cited by papers focused on Synthesis and biological activity (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Ebru Hacıosmanoğlu collaborates with scholars based in Türkiye, Austria and United States. Ebru Hacıosmanoğlu's co-authors include Halil Şenol, Feyzi Sinan Tokalı, Mayram Hacıoğlu, Cevahir Altınkaynak, Paul B. Savage, Çagla Bozkurt-Güzel, Nalan Özdemir, Cem Ekmekçioğlu, Antonio Cortese and Allison Wolf and has published in prestigious journals such as PLoS ONE, Langmuir and The FASEB Journal.

In The Last Decade

Ebru Hacıosmanoğlu

24 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebru Hacıosmanoğlu Türkiye 11 119 114 40 28 27 27 326
Jianli Liu China 15 271 2.3× 168 1.5× 68 1.7× 16 0.6× 16 0.6× 45 591
Ahmad Perwez India 15 187 1.6× 174 1.5× 22 0.6× 14 0.5× 25 0.9× 23 465
Hari Krishnareddy Rachamalla India 12 174 1.5× 61 0.5× 19 0.5× 47 1.7× 18 0.7× 27 370
Yongxiang Zheng China 11 228 1.9× 56 0.5× 37 0.9× 19 0.7× 18 0.7× 34 426
Shujuan Jin China 13 149 1.3× 145 1.3× 22 0.6× 17 0.6× 13 0.5× 28 377
Chia‐Yang Shiau Taiwan 13 223 1.9× 89 0.8× 103 2.6× 21 0.8× 13 0.5× 24 388
Shizhen Zhao China 13 168 1.4× 272 2.4× 72 1.8× 24 0.9× 51 1.9× 30 547
Hongfei Chen China 14 210 1.8× 135 1.2× 20 0.5× 19 0.7× 20 0.7× 37 429
Yunguang Qiu China 12 233 2.0× 71 0.6× 25 0.6× 18 0.6× 23 0.9× 15 401
Dipanjan Karati India 12 102 0.9× 80 0.7× 38 0.9× 24 0.9× 29 1.1× 52 335

Countries citing papers authored by Ebru Hacıosmanoğlu

Since Specialization
Citations

This map shows the geographic impact of Ebru Hacıosmanoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Hacıosmanoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Hacıosmanoğlu more than expected).

Fields of papers citing papers by Ebru Hacıosmanoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebru Hacıosmanoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Hacıosmanoğlu. The network helps show where Ebru Hacıosmanoğlu may publish in the future.

Co-authorship network of co-authors of Ebru Hacıosmanoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ebru Hacıosmanoğlu. A scholar is included among the top collaborators of Ebru Hacıosmanoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebru Hacıosmanoğlu. Ebru Hacıosmanoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hacıosmanoğlu, Ebru, Sefer Baday, Bilge Özerman Edis, et al.. (2025). Colchicine Modulates the Actin Cytoskeleton by Direct Binding to the Monomer and Facilitating Polymerization. The FASEB Journal. 39(19). e71054–e71054.
2.
Hacıosmanoğlu, Ebru, et al.. (2025). Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib. Cell Biochemistry and Function. 43(3). e70068–e70068. 2 indexed citations
4.
Hacıoğlu, Mayram, et al.. (2024). Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies. Journal of Antimicrobial Chemotherapy. 79(11). 2828–2836. 3 indexed citations
5.
Oktay, Burcu, et al.. (2023). Development of self-healing vanillin/PEI hydrogels for tissue engineering. European Polymer Journal. 188. 111933–111933. 10 indexed citations
7.
Subramanian, Kumar, Phuong L. Doan, Konda Mani Saravanan, et al.. (2023). A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL‐2/BAX and p53 in colon cancer. British Journal of Pharmacology. 181(1). 107–124. 16 indexed citations
8.
Altınkaynak, Cevahir, et al.. (2023). Anti-microbial, anti-oxidant and wound healing capabilities of Aloe vera-incorporated hybrid nanoflowers. Journal of Bioscience and Bioengineering. 135(4). 321–330. 27 indexed citations
9.
Tokalı, Feyzi Sinan, et al.. (2023). Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies. Archiv der Pharmazie. 356(11). e2300423–e2300423. 44 indexed citations
11.
Hacıosmanoğlu, Ebru, et al.. (2023). Depolymerization of actin filaments by Cucurbitacin I through binding G‐actin. Food Science & Nutrition. 12(2). 881–889. 3 indexed citations
12.
Hacıosmanoğlu, Ebru, et al.. (2023). The Inflammatory and Cytological Effect of Repeated Povidone-Iodine Application in Patients Receiving Intravitreal Injections. Eye & Contact Lens Science & Clinical Practice. 50(2). 73–78. 1 indexed citations
13.
Hacıosmanoğlu, Ebru, et al.. (2022). The melatonin MT2 receptor is involved in the anti-apoptotic effects of melatonin in rats with type 2 diabetes mellitus. Tissue and Cell. 76. 101763–101763. 7 indexed citations
14.
Şenol, Halil, et al.. (2022). Synthesis of ursolic acid arylidene-hydrazide hybrid compounds and investigation of their cytotoxic and antimicrobial effects. Natural Product Research. 37(15). 2500–2507. 24 indexed citations
15.
Hacıoğlu, Mayram, et al.. (2022). Impact of N-Acetylcysteine and Antibiotics Against Single and Dual Species Biofilms of Pseudomonas aeruginosa and Achromobacter xylosoxidans. Current Microbiology. 80(1). 5–5. 5 indexed citations
16.
17.
Hacıosmanoğlu, Ebru, et al.. (2021). A low direct electrical signal attenuates oxidative stress and inflammation in septic rats. PLoS ONE. 16(9). e0257177–e0257177. 2 indexed citations
18.
Hacıoğlu, Mayram, et al.. (2019). Effects of ceragenins and conventional antimicrobials on Candida albicans and Staphylococcus aureus mono and multispecies biofilms. Diagnostic Microbiology and Infectious Disease. 95(3). 114863–114863. 26 indexed citations
19.
Hacıosmanoğlu, Ebru, et al.. (2016). Interleukin-1β effect on the endogenous ADP-ribosylation and phosphorylation of eukaryotic elongation factor 2. Cytotechnology. 68(6). 2659–2666. 1 indexed citations
20.
Koc, Emine C., Ebru Hacıosmanoğlu, Pier Paolo Claudio, et al.. (2015). Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. Mitochondrion. 24. 113–121. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026